By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Horama 

Pépinière Paris Santé Cochin
27 rue du Faubourg Saint-Jacques
Sanofi    75014  France
Phone: n/a Fax: n/a


SEARCH JOBS

Horama is a clinical-stage biotech company that develops gene-therapy treatments, based on recombinant adeno-associated virus (rAAV) vectors, targeting rare inherited retinal diseases. The company's portfolio especially includes two products scheduled to enter into clinical trials in the coming months. Horama was founded in 2014 in Paris with the support of a group of scientists who had carried out one of the very first gene-therapy trials in ophthalmology, in 2011. These world-renowned cofounders (Philippe Moullier, Christian Hamel and Vasiliki Kalatzis of INSERM, and Michel Weber and Guylène Le Meur, of the University Hospital of Nantes) all have complementary skills.

YEAR FOUNDED:

2014

LEADERSHIP:

Chairman, Founder, Entrepreneur: Denis Cayet

TECHNOLOGY

Please click here for Horama's technology.

PIPELINE:

Please click here for Horama's pipeline.


Key Statistics


Email:
Ownership: Private

Web Site: Horama
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->